Business Context and Reporting Period
This Form 8-K Current Report was filed by Ares Capital Corporation on November 17, 2023. The filing discloses a specific corporate finance event: the issuance of additional senior unsecured notes to raise capital for debt repayment and general corporate purposes.
Key Financial Metrics and Transaction Details
- Instrument Issued: $300 million aggregate principal amount of 7.000% Notes due 2027 (New 2027 Notes).
- Issue Price: 100.170% of principal amount.
- Net Proceeds: Approximately $298.2 million after estimated offering expenses.
- Offering Expenses: Approximately $2.3 million total, including a $1.4 million underwriting discount.
- Interest Rate: 7.000% per annum, payable semiannually starting January 15, 2024.
- Maturity Date: January 15, 2027.
- Debt Structure: The New 2027 Notes are fungible with and rank equally with $600 million of Existing 2027 Notes issued in August 2023.
Material Changes and Use of Proceeds
The primary material change is the increase in the Company's outstanding indebtedness by $300 million in principal. The Company intends to use the net proceeds to repay certain outstanding indebtedness under its credit facilities. The Company may subsequently reborrow under these facilities for general corporate purposes, including investing in portfolio companies.
Outlook, Risks, and Management Commentary
The filing does not provide forward-looking guidance, earnings outlook, or specific risk factors beyond the standard terms of the debt instrument. The notes are redeemable at the Company's option at any time at redemption prices set forth in the Seventeenth Supplemental Indenture. The transaction was executed pursuant to a Purchase Agreement dated November 14, 2023, with underwriters including BofA Securities, J.P. Morgan, SMBC Nikko, and Wells Fargo.
Investor Verification Checklist
- Verify the total outstanding principal of the 7.000% Notes due 2027 (now $900 million combined).
- Confirm the specific credit facilities being repaid with the $298.2 million in net proceeds.
- Review the Seventeenth Supplemental Indenture for specific redemption price schedules and covenants.
- Assess the impact of the 7.000% interest rate on the Company's future interest expense coverage.